1 Ceftazidime Injection Market Overview 1.1 Product Overview and Scope of Ceftazidime Injection 1.2 Ceftazidime Injection Segment by Type 1.2.1 Global Ceftazidime Injection Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 1g/vial 1.2.3 2g/vial 1.2.4 6g/vial 1.3 Ceftazidime Injection Segment by Application 1.3.1 Global Ceftazidime Injection Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Recovery Center 1.4 Global Ceftazidime Injection Market Size Estimates and Forecasts 1.4.1 Global Ceftazidime Injection Revenue 2017-2028 1.4.2 Global Ceftazidime Injection Sales 2017-2028 1.4.3 Ceftazidime Injection Market Size by Region: 2017 Versus 2021 Versus 2028 2 Ceftazidime Injection Market Competition by Manufacturers 2.1 Global Ceftazidime Injection Sales Market Share by Manufacturers (2017-2022) 2.2 Global Ceftazidime Injection Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Ceftazidime Injection Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Ceftazidime Injection Manufacturing Sites, Area Served, Product Type 2.5 Ceftazidime Injection Market Competitive Situation and Trends 2.5.1 Ceftazidime Injection Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Ceftazidime Injection Players Market Share by Revenue 2.5.3 Global Ceftazidime Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Ceftazidime Injection Retrospective Market Scenario by Region 3.1 Global Ceftazidime Injection Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Ceftazidime Injection Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Ceftazidime Injection Market Facts & Figures by Country 3.3.1 North America Ceftazidime Injection Sales by Country 3.3.2 North America Ceftazidime Injection Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Ceftazidime Injection Market Facts & Figures by Country 3.4.1 Europe Ceftazidime Injection Sales by Country 3.4.2 Europe Ceftazidime Injection Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ceftazidime Injection Market Facts & Figures by Region 3.5.1 Asia Pacific Ceftazidime Injection Sales by Region 3.5.2 Asia Pacific Ceftazidime Injection Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Ceftazidime Injection Market Facts & Figures by Country 3.6.1 Latin America Ceftazidime Injection Sales by Country 3.6.2 Latin America Ceftazidime Injection Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Ceftazidime Injection Market Facts & Figures by Country 3.7.1 Middle East and Africa Ceftazidime Injection Sales by Country 3.7.2 Middle East and Africa Ceftazidime Injection Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Ceftazidime Injection Historic Market Analysis by Type 4.1 Global Ceftazidime Injection Sales Market Share by Type (2017-2022) 4.2 Global Ceftazidime Injection Revenue Market Share by Type (2017-2022) 4.3 Global Ceftazidime Injection Price by Type (2017-2022) 5 Global Ceftazidime Injection Historic Market Analysis by Application 5.1 Global Ceftazidime Injection Sales Market Share by Application (2017-2022) 5.2 Global Ceftazidime Injection Revenue Market Share by Application (2017-2022) 5.3 Global Ceftazidime Injection Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Teligent 6.1.1 Teligent Corporation Information 6.1.2 Teligent Description and Business Overview 6.1.3 Teligent Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Teligent Ceftazidime Injection Product Portfolio 6.1.5 Teligent Recent Developments/Updates 6.2 Pfizer 6.2.1 Pfizer Corporation Information 6.2.2 Pfizer Description and Business Overview 6.2.3 Pfizer Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Pfizer Ceftazidime Injection Product Portfolio 6.2.5 Pfizer Recent Developments/Updates 6.3 B Braun 6.3.1 B Braun Corporation Information 6.3.2 B Braun Description and Business Overview 6.3.3 B Braun Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.3.4 B Braun Ceftazidime Injection Product Portfolio 6.3.5 B Braun Recent Developments/Updates 6.4 Sagent 6.4.1 Sagent Corporation Information 6.4.2 Sagent Description and Business Overview 6.4.3 Sagent Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Sagent Ceftazidime Injection Product Portfolio 6.4.5 Sagent Recent Developments/Updates 6.5 WG Critical Care 6.5.1 WG Critical Care Corporation Information 6.5.2 WG Critical Care Description and Business Overview 6.5.3 WG Critical Care Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.5.4 WG Critical Care Ceftazidime Injection Product Portfolio 6.5.5 WG Critical Care Recent Developments/Updates 6.6 GSK 6.6.1 GSK Corporation Information 6.6.2 GSK Description and Business Overview 6.6.3 GSK Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.6.4 GSK Ceftazidime Injection Product Portfolio 6.6.5 GSK Recent Developments/Updates 6.7 Allergan 6.6.1 Allergan Corporation Information 6.6.2 Allergan Description and Business Overview 6.6.3 Allergan Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Allergan Ceftazidime Injection Product Portfolio 6.7.5 Allergan Recent Developments/Updates 6.8 CSPC Zhongnuo Pharmaceutical 6.8.1 CSPC Zhongnuo Pharmaceutical Corporation Information 6.8.2 CSPC Zhongnuo Pharmaceutical Description and Business Overview 6.8.3 CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.8.4 CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Product Portfolio 6.8.5 CSPC Zhongnuo Pharmaceutical Recent Developments/Updates 6.9 Anhui Welman 6.9.1 Anhui Welman Corporation Information 6.9.2 Anhui Welman Description and Business Overview 6.9.3 Anhui Welman Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Anhui Welman Ceftazidime Injection Product Portfolio 6.9.5 Anhui Welman Recent Developments/Updates 6.10 Guangzhou Baiyunshan Tianxin Pharmaceutical 6.10.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information 6.10.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview 6.10.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Product Portfolio 6.10.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates 6.11 Hainan Hailing Chemipharma 6.11.1 Hainan Hailing Chemipharma Corporation Information 6.11.2 Hainan Hailing Chemipharma Ceftazidime Injection Description and Business Overview 6.11.3 Hainan Hailing Chemipharma Ceftazidime Injection Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Hainan Hailing Chemipharma Ceftazidime Injection Product Portfolio 6.11.5 Hainan Hailing Chemipharma Recent Developments/Updates 7 Ceftazidime Injection Manufacturing Cost Analysis 7.1 Ceftazidime Injection Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ceftazidime Injection 7.4 Ceftazidime Injection Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ceftazidime Injection Distributors List 8.3 Ceftazidime Injection Customers 9 Ceftazidime Injection Market Dynamics 9.1 Ceftazidime Injection Industry Trends 9.2 Ceftazidime Injection Market Drivers 9.3 Ceftazidime Injection Market Challenges 9.4 Ceftazidime Injection Market Restraints 10 Global Market Forecast 10.1 Ceftazidime Injection Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ceftazidime Injection by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Ceftazidime Injection by Type (2023-2028) 10.2 Ceftazidime Injection Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ceftazidime Injection by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Ceftazidime Injection by Application (2023-2028) 10.3 Ceftazidime Injection Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ceftazidime Injection by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Ceftazidime Injection by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ceftazidime Injection Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Ceftazidime Injection Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Ceftazidime Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Ceftazidime Injection Market Competitive Situation by Manufacturers in 2021 Table 5. Global Ceftazidime Injection Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Ceftazidime Injection Sales Market Share by Manufacturers (2017-2022) Table 7. Global Ceftazidime Injection Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Ceftazidime Injection Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Ceftazidime Injection Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Ceftazidime Injection Manufacturing Sites and Area Served Table 11. Manufacturers Ceftazidime Injection Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ceftazidime Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ceftazidime Injection as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ceftazidime Injection Sales by Region (2017-2022) & (K Units) Table 16. Global Ceftazidime Injection Sales Market Share by Region (2017-2022) Table 17. Global Ceftazidime Injection Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Ceftazidime Injection Revenue Market Share by Region (2017-2022) Table 19. North America Ceftazidime Injection Sales by Country (2017-2022) & (K Units) Table 20. North America Ceftazidime Injection Sales Market Share by Country (2017-2022) Table 21. North America Ceftazidime Injection Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Ceftazidime Injection Revenue Market Share by Country (2017-2022) Table 23. Europe Ceftazidime Injection Sales by Country (2017-2022) & (K Units) Table 24. Europe Ceftazidime Injection Sales Market Share by Country (2017-2022) Table 25. Europe Ceftazidime Injection Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Ceftazidime Injection Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Ceftazidime Injection Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Ceftazidime Injection Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Ceftazidime Injection Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Ceftazidime Injection Revenue Market Share by Region (2017-2022) Table 31. Latin America Ceftazidime Injection Sales by Country (2017-2022) & (K Units) Table 32. Latin America Ceftazidime Injection Sales Market Share by Country (2017-2022) Table 33. Latin America Ceftazidime Injection Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Ceftazidime Injection Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Ceftazidime Injection Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Ceftazidime Injection Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Ceftazidime Injection Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Ceftazidime Injection Revenue Market Share by Country (2017-2022) Table 39. Global Ceftazidime Injection Sales by Type (2017-2022) & (K Units) Table 40. Global Ceftazidime Injection Sales Market Share by Type (2017-2022) Table 41. Global Ceftazidime Injection Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Ceftazidime Injection Revenue Share by Type (2017-2022) Table 43. Global Ceftazidime Injection Price by Type (2017-2022) & (US$/Unit) Table 44. Global Ceftazidime Injection Sales (K Units) by Application (2017-2022) Table 45. Global Ceftazidime Injection Sales Market Share by Application (2017-2022) Table 46. Global Ceftazidime Injection Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Ceftazidime Injection Revenue Share by Application (2017-2022) Table 48. Global Ceftazidime Injection Price by Application (2017-2022) & (US$/Unit) Table 49. Teligent Corporation Information Table 50. Teligent Description and Business Overview Table 51. Teligent Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Teligent Ceftazidime Injection Product Table 53. Teligent Recent Developments/Updates Table 54. Pfizer Corporation Information Table 55. Pfizer Description and Business Overview Table 56. Pfizer Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Pfizer Ceftazidime Injection Product Table 58. Pfizer Recent Developments/Updates Table 59. B Braun Corporation Information Table 60. B Braun Description and Business Overview Table 61. B Braun Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. B Braun Ceftazidime Injection Product Table 63. B Braun Recent Developments/Updates Table 64. Sagent Corporation Information Table 65. Sagent Description and Business Overview Table 66. Sagent Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Sagent Ceftazidime Injection Product Table 68. Sagent Recent Developments/Updates Table 69. WG Critical Care Corporation Information Table 70. WG Critical Care Description and Business Overview Table 71. WG Critical Care Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. WG Critical Care Ceftazidime Injection Product Table 73. WG Critical Care Recent Developments/Updates Table 74. GSK Corporation Information Table 75. GSK Description and Business Overview Table 76. GSK Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. GSK Ceftazidime Injection Product Table 78. GSK Recent Developments/Updates Table 79. Allergan Corporation Information Table 80. Allergan Description and Business Overview Table 81. Allergan Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Allergan Ceftazidime Injection Product Table 83. Allergan Recent Developments/Updates Table 84. CSPC Zhongnuo Pharmaceutical Corporation Information Table 85. CSPC Zhongnuo Pharmaceutical Description and Business Overview Table 86. CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Product Table 88. CSPC Zhongnuo Pharmaceutical Recent Developments/Updates Table 89. Anhui Welman Corporation Information Table 90. Anhui Welman Description and Business Overview Table 91. Anhui Welman Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Anhui Welman Ceftazidime Injection Product Table 93. Anhui Welman Recent Developments/Updates Table 94. Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information Table 95. Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview Table 96. Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Product Table 98. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates Table 99. Hainan Hailing Chemipharma Corporation Information Table 100. Hainan Hailing Chemipharma Description and Business Overview Table 101. Hainan Hailing Chemipharma Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Hainan Hailing Chemipharma Ceftazidime Injection Product Table 103. Hainan Hailing Chemipharma Recent Developments/Updates Table 104. Production Base and Market Concentration Rate of Raw Material Table 105. Key Suppliers of Raw Materials Table 106. Ceftazidime Injection Distributors List Table 107. Ceftazidime Injection Customers List Table 108. Ceftazidime Injection Market Trends Table 109. Ceftazidime Injection Market Drivers Table 110. Ceftazidime Injection Market Challenges Table 111. Ceftazidime Injection Market Restraints Table 112. Global Ceftazidime Injection Sales Forecast by Type (2023-2028) & (K Units) Table 113. Global Ceftazidime Injection Sales Market Share Forecast by Type (2023-2028) Table 114. Global Ceftazidime Injection Revenue Forecast by Type (2023-2028) & (US$ Million) Table 115. Global Ceftazidime Injection Revenue Market Share Forecast by Type (2023-2028) Table 116. Global Ceftazidime Injection Sales Forecast by Application (2023-2028) & (K Units) Table 117. Global Ceftazidime Injection Sales Market Share Forecast by Application (2023-2028) Table 118. Global Ceftazidime Injection Revenue Forecast by Application (2023-2028) & (US$ Million) Table 119. Global Ceftazidime Injection Revenue Market Share Forecast by Application (2023-2028) Table 120. Global Ceftazidime Injection Sales Forecast by Region (2023-2028) & (K Units) Table 121. Global Ceftazidime Injection Sales Market Share Forecast by Region (2023-2028) Table 122. Global Ceftazidime Injection Revenue Forecast by Region (2023-2028) & (US$ Million) Table 123. Global Ceftazidime Injection Revenue Market Share Forecast by Region (2023-2028) Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ceftazidime Injection Figure 2. Global Ceftazidime Injection Market Share by Type in 2021 & 2028 Figure 3. 1g/vial Product Picture Figure 4. 2g/vial Product Picture Figure 5. 6g/vial Product Picture Figure 6. Global Ceftazidime Injection Market Share by Application in 2021 & 2028 Figure 7. Hospital Figure 8. Clinics Figure 9. Recovery Center Figure 10. Global Ceftazidime Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Ceftazidime Injection Market Size (2017-2028) & (US$ Million) Figure 12. Global Ceftazidime Injection Sales (2017-2028) & (K Units) Figure 13. Ceftazidime Injection Sales Share by Manufacturers in 2021 Figure 14. Global Ceftazidime Injection Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Ceftazidime Injection Players: Market Share by Revenue in 2021 Figure 16. Ceftazidime Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Ceftazidime Injection Sales Market Share by Region (2017-2022) Figure 18. Global Ceftazidime Injection Sales Market Share by Region in 2021 Figure 19. Global Ceftazidime Injection Revenue Market Share by Region (2017-2022) Figure 20. Global Ceftazidime Injection Revenue Market Share by Region in 2021 Figure 21. U.S. Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Ceftazidime Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Ceftazidime Injection by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Ceftazidime Injection Figure 47. Manufacturing Process Analysis of Ceftazidime Injection Figure 48. Ceftazidime Injection Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Teligent Pfizer B Braun Sagent WG Critical Care GSK Allergan CSPC Zhongnuo Pharmaceutical Anhui Welman Guangzhou Baiyunshan Tianxin Pharmaceutical Hainan Hailing Chemipharma